Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising awareness among women regarding various IUD applications
3.2.1.2 High number of unintended pregnancies
3.2.1.3 Government initiatives for the prevention of unwanted abortions and pregnancies
3.2.1.4 Growing inclination towards planned delayed pregnancy
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of device
3.2.2.2 Risk of several health issues
3.2.2.3 Variability in insurance coverage and access
3.3 Growth potential analysis
3.4 Technology landscape
3.5 Future market trends
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6.3 Asia Pacific
3.7 Reimbursement scenario
3.7.1 North America
3.7.2 Europe
3.7.3 Asia Pacific
3.8 Pricing analysis
3.9 Gap analysis
3.10 Porter’s analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Copper IUD
5.3 Hormonal IUD
Chapter 6 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 15-19
6.3 20-24
6.4 25-29
6.5 30-34
6.6 35-39
6.7 40-44
6.8 45+
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Gynecology clinics
7.4 Community health care centers
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Allergan (AbbVie Inc.)
9.2 Bayer AG
9.3 Contrel Europe
9.4 CooperSurgical Inc.
9.5 Durbin
9.6 EUROGINE, S.L
9.7 Gima S.p.A.
9.8 HLL Lifecare Limited
9.9 Meril Life Sciences Pvt. Ltd.
9.10 Mona Lisa N.V.
9.11 Mylan N.V. (Viatris)
9.12 OCON Medical Ltd.
9.13 Pregna International Ltd.
9.14 Prosan International BV
9.15 SMB Corporation of India
